SPHERA FUNDS MANAGEMENT LTD. - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 123 filers reported holding RELMADA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$7,153,000
-19.3%
193,230
-58.6%
0.99%
+4.7%
Q2 2022$8,865,000
+12.8%
466,830
+60.3%
0.95%
-14.7%
Q1 2022$7,861,000
-27.0%
291,252
-39.1%
1.11%
-6.2%
Q4 2021$10,774,000478,2081.18%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders